CXCL1 and neoplasm: After adjusting for TNM staging, the expression of CXCL1 (corrected P ≥ 0.925, corrected HR (95% CI) = 0.957 (0.38 - 2.409) was not significantly correlated with tumor-free survival in COAD patients.